EULAR Task Force Ongoing Inititatives

  • QoC 001 - 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis, 2021-22
    Convenor: D. van der Heijde/S- Ramiro

  • QoC 002 - EULAR Points to Consider for the definition of clinical and imaging features suspicious for progression to psoriatic arthritis, 2021-22
    Convenor: D. McGonagle/J. Smolen

  • QoC 003 - EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritides and a recent history of cancer, 2021-22
    Convenor: J.-E. Gottenberg

  • HPR 052 - EULAR points to consider/recommendations for the management of fatigue in people with inflammatory rheumatic diseases
    Convenor: Dures-Machado

  • CLI083 - Development and validation of EULAR Systemic Sclerosis Impact of Disease (EULAR ScleroID) score
    Convenors: Oliver Distler / T. Heiberg

  • CLI88 - The Development of New Classification Criteria for Hand Osteoarthritis
    Convenor: M.Kloppenburg

  • CLI098 -  ACR-EULAR Criteria for Treatment Response for ANCA‐Associated Vasculitis
    Convenors: Peter Merkel/Gunnar Tomasson

  • CLI100 - Development of EULAR points to consider/recommendations for including the perspective of young patients with inflammatory arthritis into patient-reported outcomes measures
    Convenor:  P.Studenic

  • CLI105 - To develop EULAR recommendations regarding the comprehensive management of difficult-to-treat rheumatoid arthritis
    Convenor: G-Nagy

  • CLI107 - ACR/EULAR Classification Criteria for Antiphospholipid Syndrome
    Convenors: Doruk Erkan (ACR)/ Stephan Zuily (EULAR)

  • CLI 108 - (ACR),/Cavagna Lorenzo (EULAR)- EULAR-ACR Classification Criteria for Antisynthetase Syndrome (CLASS)
    Convenor: Aggarwal Rohit

  • CLI109 - EULAR Recommendations /Points to Consider for the intra-articular treatment of arthropathies (including synoviorthesis)
    Convenor:  Uson

  • CLI112 - EULAR Recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases (including SLE and the antiphospholipid syndrome)
    Convenors: Michael Nurmohamed / Maria Tektonidou

  • CLI113 - Development And Validation of a EULAR disease activity score in adult onset Still’s Disease: the “DAVID” project
    Convenor: R.Giacomelli

  • CLI114  - Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatology
    Convenor: J.Isaacs

  • CLI115 - Points to Consider for Conducting Clinical Trials in Individuals at risk of Rheumatoid Arthritis
    Convenor: Paul Emery

  • CLI116 - ACR-EULAR Classification Criteria for Calcium Pyrophosphate Depostion Disease (CPDD)
    Convenors: Hyon Choi / Abhishek Abhishek

  • CLI117 - EULAR Classification criteria for haemochromatosis arthropathy
    Convenor: P.Kiely

  • CLI118 - EULAR recommendations for screening and prophylaxis for opportunistic and chronic infectious diseases
    Convenor: Kimme Hyrich

  • CLI119 - ERS/EULAR Clinical practice guideline on Connective tissue diseases with Interstitial Lung (ILD) involvement: Memorandum of Understanding
    Convenor: Anna-Maria Hoffmann-Vold

  • CLI120 - Recommendations for the management of the Autoinflammatory Type-I Interferonopathies, CANDLE/PRAAS, SAVI and AGS,

    - Recommendations for the management of the IL-1-mediated Autoinflammatory Diseases, CAPS (FCAS, MWS and NOMID/CINCA), TRAPS, MKD and DIRA
    Convenor: Raphaela Goldbach-Mansky

  • CLI121 - Classification Criteria for pediatric chronic recurrent multifocal osteomyelitis (CRMO)
    Convenors: Seza Özen / Yongdong Zhao

  • CLI123 - Update of the EULAR 2020 provisional recommendations for the management of RMDs in the context of SARS-CoV-2
    Convenor: R.Landewé 

  • CLI124 - EULAR points to consider for remote care in rheumatic and musculoskeletal diseases RMDs
    Convenors: Christian Dejaco / Annette de Turah

  • IMG017 - EULAR Recommendations for the use of imaging in crystal-induced arthropathies in clinical practice
    Convenor: P. Mandl

  • IMG016 - EULAR recommendations for the use of imaging to guide interventional procedures in patients with Rheumatic and Musculoskeletal Diseases (RMD)
    Convenor: Christian Dejaco

  • IMG015 Guide/Recommendations for The Conduct, Content and Format of EULAR/PReS Paediatric Musculoskeletal Ultrasound Courses.
    Convenor: Silvia Magni Manzoni

  • IMG013 - Imaging: EULAR Recommendations for the use of imaging in patient with mechanical back pain
    Convenor:G.Fournier

  • IMG006 Development of a standardized training model for ultrasound-guided synovial biopsy’s in small and large joints
    Convenor: Ingrid Möller/Esperanza Naredo

  • IMG009 - Imaging: EULAR definition of Rheumatoid Arthritis Bone Erosion
    Convenor: Frédérique Grandjbakhch, Georg Schett

  • IMG003 - Imaging: EULAR recommendations /criteria for the appropriate use of musculoskeletal ultrasound in rheumatology clinical practice (Imaging)
    Convenor: Maria-Antonietta d'Agostino

  • Research - EULAR standardised operating procedures for implementing recommendations
    Convenor: Estibaliz Loza

  • Research - EULAR Task Force on Gender Equity in Academic Rheumatology (EULAR GEAR)
    Formerly called: EULAR Task Force to establish the evidence base and need for a EULAR Women’s Network for Academics
    Convenor: Laura Coates

  • Research - EULAR points to consider for minimal reporting requirements in synovial tissue clinical applications and research in rheumatology
    Convenor: Andrew Filer, Aurélie Najm

  • Research - EULAR recommendations/points to consider for the measurement and reporting of interferon activity in clinical research and future clinical application
    Convenor: Edward Vital

  • HPR - EULAR Implementation of a mobile health app for the self-management of juvenile-onset rheumatic and musculoskeletal diseases during transitional care: a patient-centered approach. The Move-Up implementation project
    Convenor: F. Estévez Lopez

  • HPR - EULAR recommendations/points to consider for the non-pharmacological management of connective tissue diseases with focus on systemic lupus erythematosus and systemic sclerosis
    Convenor: Carina Bostrom

  • HPR - Defining and optimising the use of qualitative research in the development of EULAR recommendations/points to consider
    Convenor: Annette de Thurah

  • HPR - Increasing work participation across Europe, part II 
    Convenor: Ross Wilkie

  • HPR - Increasing work participation across Europe 
    Convenor: Ross Wilkie

  • HPR - Implementation of Physical Activity into routine Clinical pracTice in Rheumatic Musculoskeletal Disease: The IMPACT-RMD study 
    Convenor: Georg Metsios

  • HPR - Assessing the implementation of the EULAR recommendations for patient education for people with inflammatory arthritis across Europe 
    Convenor: Mwidimi Ndosi

  • HPR - People with RMDs will act as multipliers to support others to stay in or return to paid and unpaid work 
    Convenor: Erika Mosor

Related Information

Call for Task Force members

We look for experienced investigators in the mentioned fields of rheumatology. To apply as task force member, please send your one-page letter of interest to participate and a short CV to Simona Lupatin (simona.lupatin@eular.org).

EULAR SOP for EULAR Recommendations/Points to Consider selection of task force members (PDF)


Application for Project Grants

EULAR welcomes project applications from rheumatologists across Europe designed for developing EULAR Recommendations, EULAR Criteria, EULAR Points to Consider, or similar projects.

See more


EULAR Recommendations

The EULAR Committees regularly establish and publish recommendations for the treatment of various rheumatic disorders. Each of these recommendations are developed by a Task Force of specialists in their field.

See more